ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
Dow Jones
38,686.32
1.51%
Brent Oil
81.295
0.00%
Bitcoin
67,750.54
0.40%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kalvista Pharmaceuticals (MM) (CBYL)

  7. Kalvista Pharmaceuticals (MM) (CBYL) News

CBYL

CARBYLAN THERAPEUTICS, INC. (CBYL)

Kalvista Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CBYL
DateTimeSourceHeadlineSymbolCompany
11/30/20164:25PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/30/20164:16PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/23/20165:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/23/20161:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/22/20164:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/22/20164:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/21/20164:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/08/20164:18PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
11/04/20164:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
10/28/20166:11AMEdgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
10/26/20164:17PMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
09/30/20164:59PMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
09/30/20164:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
09/23/20167:53AMPR Newswire (US)Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan...NASDAQ:CBYLKalvista Pharmaceuticals (MM)
09/12/20161:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
08/24/20166:02AMEdgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
08/12/20164:19PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
07/29/20164:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/28/20164:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/27/20165:21PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/24/20164:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/24/20164:19PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/24/20164:18PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/23/20165:30PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/22/20164:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/22/20164:46PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/22/20164:00PMGlobeNewswire Inc.Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed TransactionNASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/17/20166:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/15/20167:53AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
06/15/20167:51AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:CBYL

Your Recent History

USOTC
HMBL
HUMBL (PK)
AMEX
FOXO
FOXO Technologies
USOTC
TPTW
TPT Global Tech (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
DRNK
NoHo (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
COOP
Mr Cooper
USOTC
FSRN
Fisker (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
CEOS
CeCors (PK)
NASDAQ
AMRN
Amarin
USOTC
VPLM
Voip Pal Com (QB)
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved